^
BIOMARKER:

RET-PTC1 rearrangement

i
Other names: RET, Ret Proto-Oncogene, Proto-Oncogene Tyrosine-Protein Kinase Receptor Ret, Cadherin-Related Family Member 16, Rearranged During Transfection, RET Receptor Tyrosine Kinase, Cadherin Family Member 12, Proto-Oncogene C-Ret, CDHF12, CDHR16, PTC, Ret Proto-Oncogene (Multiple Endocrine Neoplasia And Medullary Thyroid Carcinoma 1, Hirschsprung Disease), Multiple Endocrine Neoplasia And Medullary Thyroid Carcinoma 1, Hirschsprung Disease 1, RET-ELE1, HSCR1, MEN2A, MEN2B, RET51, MTC1, PTC1, Patched Ho
Entrez ID:
News
Twitter
Trials
RET-PTC1 rearrangement
Thyroid Gland Papillary Carcinoma
MK-2206
Sensitive: D – Preclinical
RET-PTC1 rearrangement
Thyroid Gland Papillary Carcinoma
dasatinib + CI-1040
Sensitive: D – Preclinical
RET-PTC1 rearrangement
Thyroid Gland Papillary Carcinoma
dasatinib
Sensitive: D – Preclinical
RET-PTC1 rearrangement
Thyroid Gland Papillary Carcinoma
cabozantinib capsule
Sensitive: D – Preclinical
RET-PTC1 rearrangement
Thyroid Gland Papillary Carcinoma
CI-1040 + SU6656
Sensitive: D – Preclinical
RET-PTC1 rearrangement
Thyroid Gland Papillary Carcinoma
CI-1040 + PP2
Sensitive: D – Preclinical
RET-PTC1 rearrangement
Thyroid Gland Papillary Carcinoma
CI-1040
Sensitive: D – Preclinical
RET-PTC1 rearrangement
Thyroid Gland Papillary Carcinoma
AZD1480
Sensitive: D – Preclinical